Amikacin Renal Dose Adjustment by Creatinine Clearance
Aminoglycosides · renal dosing
Amikacin renal dosing by creatinine clearance (Cockcroft-Gault): the dose-adjustment rule, the key caution, and how to estimate kidney function before prescribing.
Medically reviewed by Dr. Rishi Kumar Kafle, MBBS, MD, FASN. Last reviewed October 2026.
Amikacin is dosed by creatinine clearance (Cockcroft-Gault): interval extension by CrCl; level-guided.
Reviewed and approved by Dr. Rishi Kumar Kafle, MBBS, MD, FASN. Always confirm against the label.
Renal dosing at a glance
| Parameter | Value |
|---|---|
| Renal estimate used | creatinine clearance (Cockcroft-Gault) |
| Dose adjustment | Interval extension by CrCl; level-guided |
| Key caution | nephro/ototoxicity |
| Drug class | Aminoglycosides |
How Amikacin Is Dosed by Creatinine Clearance
Amikacin is cleared, wholly or partly, by the kidneys. As filtration falls, the drug or its active metabolites clear more slowly and can accumulate, which raises the risk of nephrotoxicity and ototoxicity. The renal dose-adjustment rule for Amikacin is therefore based on creatinine clearance (Cockcroft-Gault). The summary above is reference-level; the linked FDA label is the authority for the exact numbers.
The Creatinine Clearance Dose-Band Framework
Most renally cleared drugs are adjusted across four broad creatinine clearance bands: above 50, 30-50, 15-30, and below 15 mL/min. Lowering the dose or lengthening the interval as clearance falls is the usual response. Amikacin's own cutoff (above) takes precedence over this general framework when the two differ, because each label sets its renal guidance from that drug's pharmacokinetics and therapeutic window.
| Creatinine clearance (mL/min) | Typical adjustment |
|---|---|
| > 50 | usually standard dosing |
| 30-50 | reduce dose or extend interval for many agents |
| 15-30 | further reduction; some drugs avoided |
| < 15 (or dialysis) | lowest dosing or an alternative agent; dialysis timing may matter |
Why Amikacin Accumulates as Kidney Function Falls
The kidneys normally remove Amikacin (or its active metabolites) at a rate that tracks glomerular filtration. As filtration falls, that removal slows, the drug's effective half-life lengthens, and each dose stays in the body longer before the next is given. Without adjustment, successive doses stack up and the steady-state concentration climbs into the range linked to nephrotoxicity and ototoxicity. Lowering the dose or lengthening the interval brings the average concentration back to a safe level and keeps the therapeutic effect. The cutoff is expressed in creatinine clearance (Cockcroft-Gault) rather than serum creatinine alone, because the same creatinine maps to very different clearances depending on age, sex, and body size.
Severe Impairment and Dialysis
At a creatinine clearance below 15 mL/min, or on dialysis, dosing for Amikacin usually moves to the lowest end of the range or to an alternative agent, and the timing of doses around a dialysis session can matter when the drug is dialysable. Decisions at this level of kidney function are best made with pharmacy or nephrology input and the patient's measured response, not an estimate alone. See when dialysis is started for context.
How to Calculate CrCl for Amikacin
Estimate the patient's renal function first, then apply the threshold above. Use the creatinine clearance calculator (Cockcroft-Gault) with the right dosing weight: actual body weight when it is below ideal body weight, ideal body weight up to 130% of ideal, and adjusted body weight above 130% of ideal, as in obesity. A protocol or label that states its own weight rule takes priority. For example, a 70-year-old, 70 kg patient with a serum creatinine of 1.4 mg/dL has a Cockcroft-Gault creatinine clearance near 50 mL/min, close to the band where many drugs in this class need adjustment.
Monitoring and Re-Estimating
The key caution for Amikacin is nephro/ototoxicity. Acute illness, dehydration, contrast, and other nephrotoxic drugs can lower kidney function within days, so re-estimate creatinine clearance whenever the clinical picture changes rather than relying on an old value. A creatinine that is still rising or falling has not reached steady state, and any estimate from it, including for Amikacin, is provisional until the value stabilises.
Re-check renal function and reconsider the Amikacin dose when any of the following appear, since each can signal falling clearance or early accumulation:
- a rising serum creatinine or a falling urine output;
- a new or worsened symptom consistent with nephrotoxicity and ototoxicity;
- a new nephrotoxic drug, contrast exposure, dehydration, or acute illness;
- a measured drug level outside its target range, where monitoring applies.
Special Populations
- Older adults: low muscle mass keeps serum creatinine deceptively normal, so clearance, and the safe Amikacin dose, can be lower than the lab value suggests.
- Obesity: total body weight overestimates clearance, so above 130% of ideal body weight the Cockcroft-Gault equation uses adjusted body weight instead.
- Acute kidney injury: a non-steady-state creatinine makes any estimate unreliable; dose conservatively and recheck.
Related Renal Dosing Rules
The other 3 drugs in the aminoglycosides class, with the rule each label sets:
- Gentamicin renal dosing (by CrCl): Extend interval / reduce by CrCl; trough-guided
- Plazomicin renal dosing (by CrCl): Adjust if CrCl 15-<90; TDM
- Tobramycin renal dosing (by CrCl): Interval by CrCl; level-guided
Compare all 4 agents side by side in the aminoglycosides renal dosing chart, or see related classes: other antimicrobials (includes vancomycin, also dosed with drug-level monitoring); carbapenems (other renally dosed antibiotics).
Also dosed with drug-level monitoring, in other classes: Dalteparin, Digoxin, Lithium, Vancomycin.